Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women

Abstract

Hormone therapy should probably be recommended for women who have had a hysterectomy and for those with coronary heart disease or at high risk for coronary heart disease. For other women, the best course of action is unclear.

Keywords

MedicineHormone therapyEndometrial cancerBreast cancerEstrogenHormone replacement therapy (female-to-male)MenopauseInternal medicineOsteoporosisHysterectomyHip fractureDiseaseCancerGynecologySurgery

Related Publications

HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONS

Elizabeth Barrett‐Connor , Deborah Grady

▪ Abstract Multiple observational studies suggest a marked reduction in risk of coronary heart disease (CHD) associated with postmenopausal estrogen use. A new meta-analysis pre...

1998 Annual Review of Public Health 591 citations

Medroxyprogesterone Acetate Antagonizes Inhibitory Effects of Conjugated Equine Estrogens on Coronary Artery Atherosclerosis

Michael R. Adams , Thomas C. Register , Deborah L. Golden +2 more

Although estrogen replacement therapy is associated with reduced risk of coronary heart disease and reduced extent of coronary artery atherosclerosis, the effects of combined (e...

1997 Arteriosclerosis Thrombosis and Vascu... 372 citations

The Effects of Estrogen and Selective Estrogen Receptor Modulators on Cardiovascular Risk Factors

Brian W. Walsh

A bstract : Raloxifene, a selective estrogen receptor modulator, favorably alters several markers of cardiovascular risk in healthy postmenopausal women. While many of its effec...

2001 Annals of the New York Academy of Sci... 17 citations

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

Jacques E. Rossouw , Garnet L. Anderson , Ross L. Prentice +9 more

Overall health risks exceeded benefits from use of combined estrogen plus progestin for an average 5.2-year follow-up among healthy postmenopausal US women. All-cause mortality ...

2002 JAMA 15602 citations

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women

Stephen B. Hulley

During an average follow-up of 4.1 years, treatment with oral conjugated equine estrogen plus medroxyprogesterone acetate did not reduce the overall rate of CHD events in postme...

1998 JAMA 6215 citations

Publication Info

Year: 1992
Type: review
Volume: 117
Issue: 12
Pages: 1016-1037
Citations: 2351
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2351

OpenAlex

Cite This

APA Style

                            
                                
                                    D Grady, 
                                
                                    Susan M. Rubin, 
                                
                                    Diana B. Petitti
                                
                                et al.
                            
                            (1992). 
                            Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women. 
                            Annals of Internal Medicine
                            , 117
                            (12)
                            , 1016-1037.
                            https://doi.org/10.7326/0003-4819-117-12-1016
                        

Identifiers

DOI: 10.7326/0003-4819-117-12-1016